An urgent need is to introduce an effective vaccine against Mycobacterium tuberculosis (M.
tb) infection. In the present study, a multi-stage M. tb immunodominant Fcγ1 fusion protein …

Tuberculosis (TB) remains a major health problem worldwide. Currently, the Bacilli Calmette-
Guérin (BCG) is the only available licensed TB vaccine, which has low efficacy in protection …

Introducing an effective vaccine for tuberculosis (TB) is an urgent need. Mycobacterium
tuberculosis (Mtb) Ag85 complex is suggested for making protective immunodominant …

As an ancient disease, tuberculosis (TB) is a major global health threat. Therefore, there is
an urgent need for an effective and safe anti-TB vaccine. In the current study, a delivery …

To search for more effective vaccines to enhance the immunogenicity and protective efficacy
of Mycobacterium bovis Bacille Calmette-Guerin (BCG) and to control or even eradicate …

Tuberculosis (TB) remains as a major public health problem worldwide. Identification and
selection of immunodominant antigens of Mycobacterium tuberculosis (MTB), capable of …

Ag85b and HspX of Mycobacterium tuberculosis (Mtb)(H37Rv) were expressed and purified
in this study. These two proteins were combined with another fusion protein CFP-10: ESAT-6 …

Tuberculosis (TB) remains a major infectious disease worldwide despite chemotherapy and
BCG vaccine. The efficacy of the current TB vaccine BCG varies from 0 to 80%. New …

Tuberculosis (TB) remains a major global health threat despite chemotherapy and Bacilli
Calmette–Guérin (BCG) vaccination. Therefore, a safer and more effective vaccine against …

Subunit vaccines have the potential advantage to boost Mycobacterium bovis Bacillus
Calmette‐Guérin (BCG)‐primed immunity in adults. However, most candidates are antigens …